Latest Breaking News On - Artiva biotherapeutics inc - Page 1 : comparemela.com

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ashleigh barretoMichael faermMark rotheraTheravance incViracta therapeutics incStanford universityRegeneron pharmaceuticalsHarvard business schoolHarpoon therapeutics incArtiva biotherapeutics incMerrill lynchHead of investor relations corporate communicationsColumbia universityCredit suisseInnoviva incTherapeutics appoints michael faerm

Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK® in Lupus Nephritis

Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK® in Lupus Nephritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesFred aslanJessica yinglingNicholas veomettArtiva biotherapeuticsLittle dog communications incDrug administrationGc cell corporationArtiva biotherapeutics incFast trackInvestigational new drugChief executive officerArtiva fast trackTrack designationAccelerated approval

GC Cell s Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform

/PRNewswire/ GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee.

James parkNew south walesSouth koreaWhite houseDistrict of columbiaUnited statesAustralian human research ethics committeeArtiva biotherapeutics incDrug administrationKorean ministry of foodCancer moonshotKorean ministryDrug safetyNew drugAsia pacificGc cell

DelveInsight Business Research, LLP: Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight

DelveInsight Business Research, LLP: Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesKronos bioShruti thakurRoche genentechJohnson janssenHeidelberg pharmaAbbvie teneooneBristol myers squibbPrnewswire delveinsightOmeros corporationKyowa kirin co ltdBioscience internationalModernatx incBellicum pharmaceuticalsIncyte corporation

Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight

/PRNewswire/ DelveInsight s Hematopoietic Stem Cell Transplantation Market Insights report includes a comprehensive understanding of current treatment.

United statesUnited kingdomAbbvie teneooneRoche genentechShruti thakurPrnewswire delveinsightJohnson janssenKronos bioHeidelberg pharmaBristol myers squibbXynomic pharmaceuticals incForge biologics incInc incyte corporationAntengene therapeuticsPacylex pharmaceuticalsMerck sharp dohme